268 related articles for article (PubMed ID: 31963175)
1. Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.
Li Y; Huang X; Zhang Z; Li S; Zhang J; Xia N; Zhao Q
Viruses; 2020 Jan; 12(1):. PubMed ID: 31963175
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
Wang X; Li M; Lin Z; Pan H; Tang Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2018 Nov; 36(50):7650-7658. PubMed ID: 30396752
[TBL] [Abstract][Full Text] [Related]
3. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
[TBL] [Abstract][Full Text] [Related]
4. Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods.
Zhang X; Wei M; Sun G; Wang X; Li M; Lin Z; Li Z; Li Y; Fang M; Zhang J; Li S; Xia N; Zhao Q
Vaccine; 2016 Nov; 34(48):5871-5877. PubMed ID: 27793484
[TBL] [Abstract][Full Text] [Related]
5. Lessons from hepatitis E vaccine design.
Li S; Zhang J; Xia N
Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817
[TBL] [Abstract][Full Text] [Related]
6. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
7. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
[TBL] [Abstract][Full Text] [Related]
10. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.
Zhao Q; Zhang J; Wu T; Li SW; Ng MH; Xia NS; Shih JW
J Gastroenterol; 2013 Feb; 48(2):159-68. PubMed ID: 23149436
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E vaccine development: a 14 year odyssey.
Wu T; Li SW; Zhang J; Ng MH; Xia NS; Zhao Q
Hum Vaccin Immunother; 2012 Jun; 8(6):823-7. PubMed ID: 22699438
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.
Yin X; Wang X; Zhang Z; Li Y; Lin Z; Pan H; Gu Y; Li S; Zhang J; Xia N; Zhao Q
J Pharm Biomed Anal; 2020 Jan; 177():112880. PubMed ID: 31546137
[TBL] [Abstract][Full Text] [Related]
13. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
[TBL] [Abstract][Full Text] [Related]
14. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
15. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).
Zhang X; Wei M; Pan H; Lin Z; Wang K; Weng Z; Zhu Y; Xin L; Zhang J; Li S; Xia N; Zhao Q
Vaccine; 2014 Jul; 32(32):4039-50. PubMed ID: 24892250
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
Liu P; Du Rj; Wang L; Han J; Liu L; Zhang Yl; Xia Jk; Lu Fm; Zhuang H
PLoS One; 2014; 9(1):e87600. PubMed ID: 24498149
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
18. Specific memory B cell response and participation of CD4
Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses.
Bai H; Kataoka M; Ami Y; Suzaki Y; Takeda N; Muramatsu M; Li TC
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452436
[TBL] [Abstract][Full Text] [Related]
20. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
